Oral propranolol as a new treatment for facial infantile hemangioma: Case report

Rosane da Cruz Ferreira, Francisco Romeu Locatelli Wolff, Ricardo Mörschbächer

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Hemangiomas are the most common benign tumors of infancy. Despite their selflimited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.

Original languageEnglish (US)
Pages (from-to)207-208
Number of pages2
JournalArquivos brasileiros de oftalmologia
Issue number3
StatePublished - 2011
Externally publishedYes


  • Capillary/therapy
  • Case reports
  • Hemangioma
  • Infant
  • Newborn
  • Propranolol/therapeutic use

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Oral propranolol as a new treatment for facial infantile hemangioma: Case report'. Together they form a unique fingerprint.

Cite this